Comparative Study of In Situ Loaded Antibody and PEG‐Fab NIPAAM Gels
- 4 December 2017
- journal article
- research article
- Published by Wiley in Macromolecular Bioscience
- Vol. 18 (2)
Abstract
Hydrogels can potentially prolong the release of a therapeutic protein, especially to treat blinding conditions. One challenge is to ensure that the protein and hydrogel are intimately mixed by better protein entanglement within the hydrogel. N‐isopropylacrylamide (NIPAAM) gels are optimized with poly(ethylene glycol) diacrylate (PEDGA) crosslinker in the presence of either bevacizumab or PEG conjugated ranibizumab (PEG10‐Fabrani). The release profiles of the hydrogels are evaluated using an outflow model of the eye, which is previously validated for human clearance of proteins. Release kinetics of in situ loaded bevacizumab‐NIPAAM gels displays a prolonged bimodal release profile in phosphate buffered saline compared to bevacizumab loaded into a preformed NIPAAM gel. Bevacizumab release in simulated vitreous from in situ loaded gels is similar to bevacizumab control indicating that diffusion through the vitreous rather than from the gel is rate limiting. Ranibizumab is site‐specifically PEGylated by disulfide rebridging conjugation. Prolonged and continuous release is observed with the in situ loaded PEG10‐Fabrani‐NIPAAM gels compared to PEG10‐Fabrani injection (control). Compared to an unmodified protein, there is better mixing due to PEG entanglement and compatibility of PEG10‐Fabrani within the NIPAAM‐PEDGA hydrogel. These encouraging results suggest that the extended release of PEGylated proteins in the vitreous can be achieved using injectable hydrogels.Keywords
Funding Information
- National Institutes of Health
- Medical Research Council
- National Institutes of Health
- UCL Overseas Research Student Fund
- Iraqi government
- Moorfields Special Trustees
- Helen Hamlyn Trust
- Medical Research Council
- Michael and Ilse Katz foundation
This publication has 81 references indexed in Scilit:
- The Effect of Glutathione as Chain Transfer Agent in PNIPAAm-Based Thermo-responsive Hydrogels for Controlled Release of ProteinsPharmaceutical Research, 2013
- Study In Vivo Intraocular Biocompatibility of In Situ Gelation Hydrogels: Poly(2-Ethyl Oxazoline)-Block-Poly(ε-Caprolactone)-Block-Poly(2-Ethyl Oxazoline) Copolymer, Matrigel and Pluronic F127PLOS ONE, 2013
- Pharmacokinetics of Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration: A Population ApproachInvestigative Ophthalmology & Visual Science, 2013
- Pharmacokinetics and toxicology of therapeutic proteins: Advances and challengesWorld Journal of Biological Chemistry, 2012
- Immunogenicity of Therapeutic Proteins: The Use of Animal ModelsPharmaceutical Research, 2011
- The effects of cross-linked thermo-responsive PNIPAAm-based hydrogel injection on retinal functionBiomaterials, 2011
- Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokineticsProgress in Retinal and Eye Research, 2010
- Delivery of Therapeutic ProteinsJournal of Pharmaceutical Sciences, 2010
- Influence of Antidrug Antibodies on Plectasin Efficacy and PharmacokineticsAntimicrobial Agents and Chemotherapy, 2009
- Synthesis and properties of thermo-responsive guar gum/poly(N-isopropylacrylamide) interpenetrating polymer network hydrogelsCarbohydrate Polymers, 2008